Ionis Pharmaceuticals IONS announced that the FDA has granted the Breakthrough Therapy designation to its pipeline candidate, ION582, for the treatment of Angelman syndrome (AS), a rare neurological ...

BeOne Medicines announced that the FDA granted Breakthrough Therapy Designation for sonrotoclax, a next-generation investigational BCL2 inhibitor, for adult patients with relapsed or refractory mantle ...

Cidara Therapeutics CDTX announced that the FDA has granted a Breakthrough Therapy designation to its lead pipeline candidate, CD388, for the prevention of seasonal influenza. Shares of the company ...

Cidara Therapeutics CDTX announced that the FDA has granted a Breakthrough Therapy designation to its lead pipeline candidate, CD388, for the prevention of seasonal influenza. Shares of the company ...